1 MedTech Manufacturing Consortium to Help Local Industry ...

Annex 5Strong Participation from Industry“To fully develop Singapore’s medical technology, a concerted effort with differentexpertise ranging from government agencies to industry players is critical. Thispartnership forms the value-chain, tapping on the expertise from research instiutes,academia and industry to develop breakthrough in medical technology and accelerateadoption of these new technology to the market.”Mr Mark Tan, Managing Director, Acme Monaco Asia Pte Ltd“We believe that the establishment of the MedTech Manufacturing Consortium willstrengthen the entire value chain proposition for Singapore as a leading country for biomedicalproducts manufacturing. Together with A*STAR and SIMTech, local SMEs orEMS providers like Beyonics will benefit from the upfront participation and accessibilityto the latest developments in the bio-medical industry, generating businessopportunities.”Mr Goh Chan Peng, Chief Executive Officer, Beyonics International Pte Ltd.“A platform like the MedTech Manufacturing Consortium is a win-win situation for allparties involved. The very clear and methodical way it is set up gives us the confidenceto participate.”Mr Hans Kunen, Managing Director, Delcam SEA Pte Ltd.“Leveraging on the enhanced support, range and depth of resources from theconsortium, we shall be in a better position to successfully overcome key challengesposed by the MedTech manufacturing industry, with high barriers of entry.”Mr Raymond Yee, Vice President, Corporate Development, Fischer Tech Ltd“There is now a window of opportunity for Singapore to move ahead of competitors andup the value chain via innovation.”Mr Lim Teck Sin, Founder of KOOPrime Pte Ltd14